For the past quarter-century, the gold standard malaria treatment has been artemisinin combination therapies (ACTs). Yet ...

Novartis plans to seek quick regulatory approvals from health authorities for the drug, known as GanLum, which would be the ...

Anopheles funestus, a malaria-transmitting mosquito. [James Gathany, Dr. Frank Collins, University of Notre Dame, courtesy of CDC] Over 247 million cases and 619,000 deaths of malaria were reported in ...

Swiss pharmaceutical giant Novartis has unveiled a next-generation malaria treatment that not only demonstrates a 97% cure ...

With almost 250 million cases a year, 621,000 of them fatal, malaria remains a major public health problem, particularly in sub-Saharan Africa. Malaria is a parasitic disease transmitted by mosquitoes ...

Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Unica Cardoso, 35, center in blue-purple headwrap, waits in line for ...

A groundbreaking study combined novel experimental data within an innovative modeling framework to examine how temperature might affect transmission risk of malaria in different environments in Africa ...

* Press release title: ‘Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance’. There is no full paper ...

A New Jersey resident has developed a case of malaria without having traveled internationally, potentially making it the first locally transmitted case in decades, state health officials say. The ...

Malaria is a potentially fatal illness that typically causes acute sickness, shaking chills and fever, according to Mayo Clinic. It is caused by parasites that are transmitted to humans through ...